Sector ratings GlaxoSmithKline Pharmaceuticals Limited

Stocks

Market Closed - Bombay S.E. Other stock markets 06:00:52 2026-07-23 EDT			5-day change	1st Jan Change
2,494.20 ^INR	-2.23%		+0.34%	+0.94%

05-29	GlaxoSmithKline Pharmaceuticals Limited Announces Resignation of Dr. Simrat Sohal from Compliance Officer and Ceases to Be the Senior Management Personnel, Effective August 5, 2026	CI
05-13	GlaxoSmithKline Pharmaceuticals Clocks Higher Fiscal Q4 Consolidated Net Profit	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED	4.48B	-	-	-		-
ELI LILLY AND COMPANY	1,037B		A
JOHNSON & JOHNSON	615B		BBB
ABBVIE INC.	448B		AA	-
ROCHE HOLDING AG	326B		AA
NOVARTIS AG	293B		AAA
ASTRAZENECA PLC	264B		A
NOVO NORDISK A/S	216B		A
AMGEN INC.	198B		A
GILEAD SCIENCES, INC.	162B		AA
PFIZER INC.	141B		A
BRISTOL-MYERS SQUIBB COMPANY	124B		A
VERTEX PHARMACEUTICALS INCORPORATED	120B		AA
SANOFI	105B		AA
GSK PLC	102B		AA
CHUGAI PHARMACEUTICAL CO., LTD.	73.72B		AA
ALLERGAN PLC	63.66B	-	-	-	-	-	-	-
TAKEDA PHARMACEUTICAL COMPANY LIMITED	54.35B		AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	53.93B		AA
BAYER AG	52.66B		AA
Average	222.65B		AA
Weighted average by Cap.			AA